Shaanxi adjusts the price limit of abiolone acetate and apixaban acetate
All medical institutions: according to the application of the enterprise, for abiolone acetate tablets (drug No.: 8184934, specification: 0.25g * 60 Tablets) and apixaban tablets (drug No.: 8185965, specification: 2.5mg) produced by Zhengda Tianqing Pharmaceutical Group Co., Ltd *The price limit of 14 tablets) was adjusted to 1436 yuan and 350 yuan respectively; the price limit of abitrone acetate tablets (drug No.: 8184933, specification: 0.25g * 120 tablets) produced by Chengdu Shengdi Pharmaceutical Co., Ltd. was adjusted to 3828 yuan. The adjusted price of the above-mentioned drugs shall be implemented from now on. Shaanxi public resources trading center February 18, 2020
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
Reta10mg Retatrutide10mg 15mg 30mg Top Fat Burning Peptides Lyophilized 5mg 10mg/Vial Peptides Powder GLP-1 Retatrutide 2381089-83-2
$194.75/UNIT FOB
Manufacturer Supply 99% High Quality Mots C/Tirze/Cagri/Ghk-Cu/Nad+ Reta CAS 1627580-64-6
$75/UNIT FOB
2026-07-18
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
-
Pharmaceutical and Health Industry Special Study - The Arrival of New Opportunities
-
Accelerate Technological Breakthroughs in Product Innovation and Promote the Industrialization and Application of Innovative Drugs
-
The Rare Disease Market Continues to Heat Up. How Will The Global Top 10 Pharmaceutical Companies by Revenue in 2021 be Deployed?
Recommend Reading
-
West Asia Tensions Squeeze Pharma Raw Materials
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
In April, the Chinese phenol market continued to decline
-
Business Society: Bisphenol A Market Down in April; Future Outlook Hard to Be Optimistic
-
In April, China's gasoline and diesel market trends declined
-
ANVISA Updates Additive Rules
-
Ethylene Oxide Prices Drop Sharply in Early June